Estimates Revisions SELLAS Life Sciences Group, Inc.
Stocks
SLS
US81642T2096
Biotechnology & Medical Research
|
Real-time Estimate
Cboe BZX
22:42:12 02/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 13.85 USD | +4.77% |
|
+0.36% | +265.52% |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Stocks
- SLS Stock
- Consensus SELLAS Life Sciences Group, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
